Skip to main content
TipRanks
Go Ultimate75% OFF

Jamieson Wellness Inc (2JW) AI Stock Analysis

0 Followers
DE:2JW

Jamieson Wellness Inc

(Frankfurt:2JW)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Steady Revenue GrowthSustained revenue expansion indicates continued demand for Jamieson’s consumer health products and broader market reach. Although growth has moderated from earlier peaks, ongoing top-line progress can support scale benefits, retailer relevance, and continued investment in the brand.
Negative Factors
Rising LeverageLeverage has risen materially compared with earlier years, reducing financial flexibility relative to the company’s prior position. Higher debt relative to equity can constrain future investment and capital allocation, while making the business more sensitive to weaker earnings or cash generation.

Jamieson Wellness Inc (2JW) vs. iShares MSCI Germany ETF (EWG)

-10%0%10%20%30%40%DE:2JW+34.86%EWG+6.38%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 1.89B
Dividend Yield
2.01%
Average Volume (3M)
―
Price to Earnings (P/E)
24.3
Beta (1Y)
0.25
Revenue Growth
8.08%
EPS Growth
26.69%
Country
Germany
Employees
891
Sector
Consumer Defensive
Sector Strength
62
Industry
Packaged Foods

Jamieson Wellness Inc Business Overview & Revenue Model

Company Description

Jamieson Wellness Inc. is a natural health products company involved in the development, manufacturing, marketing, and distribution of its offerings across Canada and internationally. The enterprise operates through two core segments. Its Jamieson Br...

Jamieson Wellness Inc Earnings Call Summary

Earnings Call Date:Feb 26, 2026(Q4-2025)|% Change Since:21.58%|Next Earnings Date:Oct 29, 2026
Earnings Call SentimentPositive

The call conveyed a broadly positive outlook backed by strong top-line growth (branded and consolidated), margin expansion, robust China execution, improved adjusted profitability and shareholder returns (buybacks/dividends). Key near-term headwinds include a decline in strategic partner revenues, higher SG&A (including one-time due diligence costs), and a working-capital build tied to inventory and tariff mitigation. Management provided confident 2026 guidance with continued China and U.S. growth expectations and targets for higher adjusted EBITDA and EPS, suggesting momentum outweighs the manageable operational and investment-related pressures.

Positive Updates

Strong Consolidated and Branded Revenue Growth
Full-year consolidated revenue grew ~12%, branded business nearly +16% (FY2025). Q4 consolidated revenue rose 13.4% to $277.7M. Jamieson Brands grew 17.1% in Q4 to $237.4M. Youtheory grew 20.2% in Q4. China was a major driver (FY growth >56%, Q4 +43.9%). International revenue up 24% for the year (Q4 +39.2%). Canada outpaced the market with ~6% full-year growth (Q4 +5.5%).

Negative Updates

Strategic Partners Revenue Decline
Strategic Partner revenues declined 4.4% in Q4 (down ~$1.9M) and gross profit in Strategic Partners decreased 2.4% in the quarter, driven by lower volumes and timing of customer onboarding related to trade/tariff uncertainties.

Company Guidance

Management guided 2026 consolidated revenue of $895–$935 million (up ~9% to almost 14%), with Jamieson Brands revenue of $790–$820 million (≈9%–13% growth); by region they forecast China +20%–30%, U.S. +14%–19% (USD), Canada +4%–6%, International +10%–15% (USD), and Strategic Partner revenues returning to growth of +10%–20%. They expect adjusted EBITDA of $174–$181 million (up ~9%–13.4%) with adjusted EBITDA margins ~19.4%, adjusted diluted EPS of $2.08–$2.21 (up 12.5%–19.5%), and cash from operations before working capital of $120–$130 million (up 9%–19%); working capital is expected to increase $25–$35 million and capital expenditures to be approximately $20 million.

Jamieson Wellness Inc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

DE:2JW against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
TSE:BUTSE:BU45NeutralCAD 12.38M-0.82338.06%―556.85%-11.49%
TSE:NPRATSE:NPRA44NeutralCAD 42.88M-30.0930.14%―32.91%55.73%

* Consumer Defensive Sector Average

Performance Comparison

0%200%400%DE:2JWTSE:BUTSE:DTEATSE:MOOO.XTSE:NPRADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:2JW and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:2JWJamieson Wellness28.407.7337.40%
TSE:BUBurcon Nutrascience Corporation0.94-1.06-53.00%
TSE:DTEADavidstea Inc.1.220.3134.07%
TSE:MOOO.XHappy Supplements Inc.0.35-0.15-30.00%
TSE:NPRANepra Foods, Inc.0.340.21161.54%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.